Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March-2020 Volume 45 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2020 Volume 45 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis

  • Authors:
    • Huizheng Mao
    • Chunling Jiang
    • Leilei Xu
    • Dapeng Chen
    • Hui Liu
    • Yuefei Xu
    • Keli Ma
    • Min Wang
  • View Affiliations / Copyright

    Affiliations: College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Laboratory Animal Center, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Department of Physiology, College of Medicine, Jiaxing University, Jiaxing, Zhejiang 314001, P.R. China
  • Pages: 939-946
    |
    Published online on: January 15, 2020
       https://doi.org/10.3892/ijmm.2020.4466
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute kidney injury (AKI) is characterized by abrupt kidney dysfunction. It results in remote organ dysfunction, including the brain. The underlying mechanism of the kidney‑brain axis in AKI and effective protective approaches remain unknown. The present study aimed to investigate the potential protective effect of ginsenoside (GS) on AKI induced by glycerol in rats. Kidney function was initially assessed by blood urea nitrogen (BUN) and creatinine (Cre) tests, and was identified to be severely impaired following glycerol treatment, based on significant increases in BUN and Cre levels observed. Severe extensive necrosis of the majority of the renal tubules was observed by hematoxylin and eosin staining, additionally confirming that glycerol induced AKI. GS was identified to ameliorate the impairment of kidney function in the context of AKI. Further investigation of the mechanism revealed that GS may induce protection against oxidative stress via a kidney‑brain axis. Furthermore, GS improved the activation of hypoxia‑inducible factor 1α (HIF‑1α) and vascular endothelial growth factor A (VEGF‑A) in the hypothalamus response to AKI, and in the kidney tissues. The protective effect of GS in AKI may be associated with the interaction between the kidney and the brain. Taken together, these results suggested that GS was involved in the protective effects against AKI by decreasing oxidative damage to the kidney and brain, and by upregulating HIF‑1α and VEGF‑A levels in the kidney‑brain axis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Malek M: Brain consequence of acute kidney injury: Focusing on the hippocampus. Kidney Res Clin Pract. 37:315–322. 2018. View Article : Google Scholar

2 

Makris K and Spanou L: Acute kidney injury: Definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 37:85–98. 2016.

3 

Lu R, Kiernan MC, Murray A, Rosner MH and Ronco C: Kidney-brain crosstalk in the acute and chronic setting. Nat Rev Nephrol. 11:707–719. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Wu J, Pan X, Fu H, Zheng Y, Dai Y, Yin Y, Chen Q, Hao Q, Bao D and Hou D: Effect of curcumin on glycerol-induced acute kidney injury in rats. Sci Rep. 7:101142017. View Article : Google Scholar : PubMed/NCBI

5 

Al Asmari AK, Al Sadoon KT, Obaid AA, Yesunayagam D and Tariq M: Protective effect of quinacrine against glycerol-induced acute kidney injury in rats. BMC Nephrol. 18:412017. View Article : Google Scholar : PubMed/NCBI

6 

Panizo N, Rubio-Navarro A, Amaro-Villalobos JM, Egido J and Moreno JA: Molecular mechanisms and novel therapeutic approaches to rhabdomyolysis-induced acute kidney injury. Kidney Blood Press Res. 40:520–532. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G and Massy ZA: Cognitive disorders and dementia in CKD: The neglected kidney-brain axis. J Am Soc Nephrol. 24:353–363. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Chen S, Li X, Wang Y, Mu P, Chen C, Huang P and Liu D: Ginsenoside Rb1 attenuates intestinal ischemia/reperfu-sion-induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Mol Med Rep. 19:3633–3641. 2019.PubMed/NCBI

9 

Xu ZM, Li CB, Liu QL, Li P and Yang H: Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice. Int J Mol Sci. 19:pii: E3658. 2018. View Article : Google Scholar

10 

Lü JM, Jiang J, Jamaluddin MS, Liang Z, Yao Q and Chen C: Ginsenoside Rb1 blocks ritonavir-induced oxidative stress and eNOS downregulation through activation of estrogen receptor-beta and upregulation of SOD in human endothelial cells. Int J Mol Sci. 20:pii: E294. 2019. View Article : Google Scholar

11 

Van Kampen J, Robertson H, Hagg T and Drobitch R: Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp Neurol. 184:521–529. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Yang Q, Lin J, Zhang H, Liu Y, Kan M, Xiu Z, Chen X, Lan X, Li X, Shi X, et al: Ginsenoside compound K regulates amyloid β via the Nrf2/Keap1 signaling pathway in mice with scopolamine hydrobromide-induced memory impairments. J Mol Neurosci. 67:62–71. 2019. View Article : Google Scholar

13 

Xu TZ, Shen XY, Sun LL, Chen YL, Zhang BQ, Huang DK and Li WZ: Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome some signalling pathway in hippocampal neurons in vitro. Int J Mol Med. 43:717–726. 2019.

14 

Chen L, Yao H, Chen X, Wang Z, Xiang Y, Xia J, Liu Y and Wang Y: Ginsenoside Rg1 decreases oxidative stress and down-regulates Akt/mTOR signalling to attenuate cognitive impairment in mice and senescence of neural stem cells induced by D-galactose. Neurochem Res. 43:430–440. 2018. View Article : Google Scholar

15 

Qiu S, Chen X, Pang Y and Zhang Z: Lipocalin-2 protects against renal ischemia/reperfusion injury in mice through autophagy activation mediated by HIF1α and NF-κB crosstalk. Biomed Pharmacother. 108:244–253. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Yang J, Liu C, Du X, Liu M, Ji X, Du H and Zhao H: Hypoxia inducible factor 1α plays a key role in remote ischemic preconditioning against stroke by modulating inflammatory responses in rats. J Am Heart Assoc. 7:pii: e007589. 2018. View Article : Google Scholar

17 

Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM and Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol. 48:285–296. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Fan X, Heijnen CJ, van der Kooij MA, Groenendaal F and van Bel F: The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res Rev. 62:99–108. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Conde E, Alegre L, Blanco-Sánchez I, Sáenz-Morales D, Aguado-Fraile E, Ponte B, Ramos E, Sáiz A, Jiménez C, Ordoñez A, et al: Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS One. 7:e332582012. View Article : Google Scholar : PubMed/NCBI

20 

Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P and Maxwell PH: Inhibition of hypoxia inducible factor hydroxy-lases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 19:39–46. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Palazon A, Tyrakis PA, Macias D, Veliça P, Rundqvist H, Fitzpatrick S, Vojnovic N, Phan AT, Loman N, Hedenfalk I, et al: An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer cell. 32:669–683. 2017. View Article : Google Scholar

22 

Ho QT and Kuo CJ: Vascular endothelial growth factor: Biology and therapeutic applications. Int J Biochem Cell Biol. 39:1349–1357. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Huang Q, Zhong W, Hu Z and Tang X: A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke. J Neuroinflammation. 15:3482018. View Article : Google Scholar : PubMed/NCBI

24 

Singh Angom R, Wang Y, Wang E, Pal K, Bhattacharya S, Watzlawik JO, Rosenberry TL, Das P and Mukhopadhyay D: VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells. FASEB J. 33:4626–4637. 2019. View Article : Google Scholar

25 

Greenberg DA and Jin K: From angiogenesis to neuropathology. Nature. 438:954–959. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Zhang HA, Wang M, Zhou J, Yao QY, Ma JM and Jiang CL: Protective effect of ginsenoside against acute renal failure and expression of tyrosine hydroxylase in the locus coeruleus. Physiol Res. 59:61–70. 2010.

27 

Tian Z, Ren N, Wang J, Zhang D and Zhou Y: Ginsenoside ameliorates cognitive dysfunction in type 2 diabetic gotokakizaki rats. Med Sci Monit. 24:3922–3928. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Song N, Zhang T, Xu X, Lu Z, Yu X, Fang Y, Hu J, Jia P, Teng J and Ding X: miR-21 protects against ischemia/reperfusion-induced acute kidney injury by preventing epithelial cell apoptosis and inhibiting dendritic cell maturation. Front Physiol. 9:7902018. View Article : Google Scholar : PubMed/NCBI

29 

Zhang Y, Nakano D, Guan Y, Hitomi H, Uemura A, Masaki T, Kobara H, Sugaya T and Nishiyama A: A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. Kidney Int. 94:524–535. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Tanaka T, Kojima I, Ohse T, Inagi R, Miyata T, Ingelfinger JR, Fujita T and Nangaku M: Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol. 289:F1123–F1133. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Wang H, Misaki T, Taupin V, Eguchi A, Ghosh P and Farquhar MG: GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin. J Am Soc Nephrol. 26:314–327. 2015. View Article : Google Scholar :

32 

Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A and Greenberg DA: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 111:1843–1851. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Storkebaum E, Lambrechts D and Carmeliet P: VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays. 26:943–954. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mao H, Jiang C, Xu L, Chen D, Liu H, Xu Y, Ma K and Wang M: Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis. Int J Mol Med 45: 939-946, 2020.
APA
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y. ... Wang, M. (2020). Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis. International Journal of Molecular Medicine, 45, 939-946. https://doi.org/10.3892/ijmm.2020.4466
MLA
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y., Ma, K., Wang, M."Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis". International Journal of Molecular Medicine 45.3 (2020): 939-946.
Chicago
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y., Ma, K., Wang, M."Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis". International Journal of Molecular Medicine 45, no. 3 (2020): 939-946. https://doi.org/10.3892/ijmm.2020.4466
Copy and paste a formatted citation
x
Spandidos Publications style
Mao H, Jiang C, Xu L, Chen D, Liu H, Xu Y, Ma K and Wang M: Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis. Int J Mol Med 45: 939-946, 2020.
APA
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y. ... Wang, M. (2020). Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis. International Journal of Molecular Medicine, 45, 939-946. https://doi.org/10.3892/ijmm.2020.4466
MLA
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y., Ma, K., Wang, M."Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis". International Journal of Molecular Medicine 45.3 (2020): 939-946.
Chicago
Mao, H., Jiang, C., Xu, L., Chen, D., Liu, H., Xu, Y., Ma, K., Wang, M."Ginsenoside protects against AKI via activation of HIF‑1α and VEGF‑A in the kidney‑brain axis". International Journal of Molecular Medicine 45, no. 3 (2020): 939-946. https://doi.org/10.3892/ijmm.2020.4466
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team